Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer

Importance Many established breast cancer risk factors are used in clinical risk prediction models, although the proportion of breast cancers explained by these factors is unknown. Objective To determine the population-attributable risk proportion (PARP) for breast cancer associated with clinical breast cancer risk factors among premenopausal and postmenopausal women. Design, Setting, and Participants Case-control study with 1:10 matching on age, year of risk factor assessment, and Breast Cancer Surveillance Consortium (BCSC) registry. Risk factor data were collected prospectively from January 1, 1996, through October 31, 2012, from BCSC community-based breast imaging facilities. A total of 18 437 women with invasive breast cancer or ductal carcinoma in situ were enrolled as cases and matched to 184 309 women without breast cancer, with a total of 58 146 premenopausal and 144 600 postmenopausal women enrolled in the study. Exposures Breast Imaging Reporting and Data System (BI-RADS) breast density (heterogeneously or extremely dense vs scattered fibroglandular densities), first-degree family history of breast cancer, body mass index (>25 vs 18.5-25), history of benign breast biopsy, and nulliparity or age at first birth (≥30 years vs <30 years). Main Outcomes and Measures Population-attributable risk proportion of breast cancer. Results Of the 18 437 women with breast cancer, the mean (SD) age was 46.3 (3.7) years among premenopausal women and 61.7 (7.2) years among the postmenopausal women. Overall, 4747 (89.8%) premenopausal and 12 502 (95.1%) postmenopausal women with breast cancer had at least 1 breast cancer risk factor. The combined PARP of all risk factors was 52.7% (95% CI, 49.1%-56.3%) among premenopausal women and 54.7% (95% CI, 46.5%-54.7%) among postmenopausal women. Breast density was the most prevalent risk factor for both premenopausal and postmenopausal women and had the largest effect on the PARP; 39.3% (95% CI, 36.6%-42.0%) of premenopausal and 26.2% (95% CI, 24.4%-28.0%) of postmenopausal breast cancers could potentially be averted if all women with heterogeneously or extremely dense breasts shifted to scattered fibroglandular breast density. Among postmenopausal women, 22.8% (95% CI, 18.3%-27.3%) of breast cancers could potentially be averted if all overweight and obese women attained a body mass index of less than 25. Conclusions and Relevance Most women with breast cancer have at least 1 breast cancer risk factor routinely documented at the time of mammography, and more than half of premenopausal and postmenopausal breast cancers are explained by these factors. These easily assessed risk factors should be incorporated into risk prediction models to stratify breast cancer risk and promote risk-based screening and targeted prevention efforts.

[1]  C. Weinberg,et al.  Use and misuse of population attributable fractions. , 1998, American journal of public health.

[2]  C. Vachon,et al.  Mammographic density phenotypes and risk of breast cancer: a meta-analysis. , 2014, Journal of the National Cancer Institute.

[3]  Ronilda C. Lacson,et al.  Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study. , 2016, Annals of internal medicine.

[4]  Karla Kerlikowske,et al.  Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.

[5]  Oguzhan Alagoz,et al.  Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. , 2016, Annals of internal medicine.

[6]  N. Boyd,et al.  Mammographic density and breast cancer risk: current understanding and future prospects , 2011, Breast Cancer Research.

[7]  F. Nicolantonio,et al.  Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer , 2017, Journal of the National Cancer Institute.

[8]  Stephen W Duffy,et al.  Tamoxifen and breast density in women at increased risk of breast cancer. , 2004, Journal of the National Cancer Institute.

[9]  A. Trentham-Dietz,et al.  Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. , 2008, American journal of epidemiology.

[10]  J. Brisson,et al.  Tamoxifen and mammographic breast densities. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  C. la Vecchia,et al.  Population attributable risk for breast cancer: diet, nutrition, and physical exercise. , 1998, Journal of the National Cancer Institute.

[12]  Rongwei Fu,et al.  Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review for the U.S. Preventive Services Task Force , 2013, Annals of Internal Medicine.

[13]  Karla Kerlikowske,et al.  One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[14]  J Benichou,et al.  Proportion of breast cancer cases in the United States explained by well-established risk factors. , 1995, Journal of the National Cancer Institute.

[15]  D. Venzon,et al.  Effect of tamoxifen on mammographic density. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  Richard J. K. Taylor,et al.  Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia. , 2013, Maturitas.

[17]  D. Miglioretti,et al.  Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. , 2007, Journal of the National Cancer Institute.

[18]  E A Sickles,et al.  Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. , 1997, Journal of the National Cancer Institute.

[19]  C. Boetes,et al.  Density is in the eye of the beholder: visual versus semi-automated assessment of breast density on standard mammograms , 2011, Insights into Imaging.

[20]  J. Hayes Population-attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Schwab,et al.  Reproductive risk factors and breast cancer subtypes: a review of the literature , 2014, Breast Cancer Research and Treatment.

[22]  Karla Kerlikowske,et al.  Benign breast disease, mammographic breast density, and the risk of breast cancer. , 2013, Journal of the National Cancer Institute.

[23]  J. Chang-Claude,et al.  Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors. , 2011, Cancer epidemiology.

[24]  Diana L Miglioretti,et al.  Reproducibility of BI‐RADS Breast Density Measures Among Community Radiologists: A Prospective Cohort Study , 2012, The breast journal.

[25]  D. Miglioretti,et al.  Misclassification of Breast Imaging Reporting and Data System (BI‐RADS) Mammographic Density and Implications for Breast Density Reporting Legislation , 2015, The breast journal.

[26]  L. Liberman,et al.  Breast imaging reporting and data system (BI-RADS). , 2002, Radiologic clinics of North America.

[27]  M. McEntee,et al.  Assessment of Interradiologist Agreement Regarding Mammographic Breast Density Classification Using the Fifth Edition of the BI-RADS Atlas. , 2016, AJR. American journal of roentgenology.

[28]  D P Byar,et al.  Estimating the population attributable risk for multiple risk factors using case-control data. , 1985, American journal of epidemiology.

[29]  Ivar Heuch,et al.  Population attributable risk for breast cancer: diet, nutrition, and physical exercise. , 2000 .

[30]  C. Weinberg,et al.  Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. , 1998, American journal of epidemiology.

[31]  D. Evans,et al.  Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.

[32]  S. Cummings,et al.  Risk Factors That Increase Risk of Estrogen Receptor–Positive and –Negative Breast Cancer , 2017, Journal of the National Cancer Institute.

[33]  H. Adami,et al.  Postmenopausal breast cancer in Iran; risk factors and their population attributable fractions , 2012, BMC Cancer.

[34]  Karla Kerlikowske,et al.  Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening. , 2016, Radiology.

[35]  J Benichou,et al.  Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models. , 1990, Biometrics.

[36]  R. Goldbohm,et al.  The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors , 2015, Breast Cancer Research and Treatment.

[37]  V. Beral,et al.  Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer , 2012, International journal of cancer.

[38]  Erratum to: Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea , 2016, BMC Cancer.

[39]  J. Brisson,et al.  Tamoxifen and Mammographic Breast Densities 1 , 2000 .

[40]  M. García-Closas,et al.  Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  Obesity in Adults,et al.  Identification, Evaluation, and Treatment of Overweight and Obesity , 2021, Obesity Prevention and Treatment.

[42]  R. Warren,et al.  Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  N. Fuente,et al.  Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies , 2011 .

[44]  C. Ogden,et al.  Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960-1962 Through 2009-2010 , 2012 .

[45]  K. Kerlikowske,et al.  Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. , 1997, AJR. American journal of roentgenology.

[46]  D. Kopans An open letter to panels that are deciding guidelines for breast cancer screening , 2015, Breast Cancer Research and Treatment.

[47]  S. Glaser,et al.  Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors , 2006, BMC Cancer.

[48]  P. Narula MAMMOGRAPHIC DENSITY AND THE RISK AND DETECTION OF BREAST CANCER , 2016 .

[49]  Karla Kerlikowske,et al.  Prevalence of mammographically dense breasts in the United States. , 2014, Journal of the National Cancer Institute.

[50]  N. Boyd,et al.  Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.